10/16/2024 5:14 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:35 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:28 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:25 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:17 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:10 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024 7:49 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
09/30/2024 4:29 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024 4:34 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 6:30 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 6:31 PM | DiRaimondo Thomas (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 6:32 PM | Janux Therapeutics (Issuer) Meyer Andrew Hollman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 5:31 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 4:05 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:51 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:51 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:54 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:18 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:01 PM | Janux Therapeutics (Subject) Meyer Andrew Hollman (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:05 PM | Campbell David Alan (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024 4:57 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024 4:35 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024 4:13 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 8:35 PM | Janux Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
09/16/2024 8:41 PM | Avalon Ventures XI, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2024 4:01 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 8:18 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 7:54 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 8:07 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 7:42 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 5:23 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:51 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144/A | |
09/11/2024 10:20 AM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144/A | |
09/10/2024 5:26 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 5:32 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 5:22 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 4:51 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 4:02 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 3:13 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024 5:03 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024 5:09 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Trump or Kamala? It may come down to this strange twist… (Ad) Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia?
To uncover the full story and learn how you can potentially profit from it... watch my new documentary here. |
09/09/2024 2:35 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144/A | |
09/09/2024 1:28 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024 6:11 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024 6:14 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024 6:17 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024 6:06 PM | Dobek Maria (Reporting) Janux Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/07/2024 3:20 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 3:28 PM | Janux Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 7:00 PM | Hernday Natasha (Reporting) Janux Therapeutics (Issuer)
| Form 4/A | |
07/24/2024 7:00 PM | DOBMEIER ERIC (Reporting) Janux Therapeutics (Issuer)
| Form 4/A | |
07/22/2024 7:01 PM | Hernday Natasha (Reporting) Janux Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/22/2024 7:01 PM | DOBMEIER ERIC (Reporting) Janux Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/22/2024 7:03 PM | Hernday Natasha (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 7:04 PM | DOBMEIER ERIC (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 4:00 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2024 3:30 PM | CAPPS VICKIE L (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Janux Therapeutics (Issuer) Simson Jake (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Barrett Ronald W (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Gujrathi Sheila (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Janux Therapeutics (Issuer) Kung Winston (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Janux Therapeutics (Issuer) McNulty Alana B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:35 PM | Janux Therapeutics (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund II, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:19 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:23 PM | Janux Therapeutics (Issuer) Reardon Tighe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:25 PM | Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:28 PM | Avalon Ventures XI, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SC 13D/A | |
06/03/2024 5:58 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 6:02 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 5:48 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 8:13 AM | Janux Therapeutics (Filer)
| Form S-3ASR | |
05/07/2024 7:05 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:14 PM | Janux Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 3:16 PM | Janux Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024 3:20 PM | Janux Therapeutics (Filer)
| Form DEFA14A | |
03/08/2024 3:47 PM | Janux Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/08/2024 3:23 PM | Janux Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/06/2024 5:54 PM | Janux Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
03/06/2024 3:15 PM | Janux Therapeutics (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund II, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 7:07 PM | Avalon Ventures XI, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SC 13D/A | |
03/04/2024 6:31 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:44 PM | Gujrathi Sheila (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:33 PM | CAPPS VICKIE L (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:30 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
02/29/2024 4:11 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 8:55 PM | Janux Therapeutics (Subject)
| Form FWP | |
02/28/2024 4:15 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 8:50 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
02/27/2024 4:23 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:43 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Janux Therapeutics (Subject)
| Form SC 13G/A | |
Election warning coming true… (Ad) If you missed it, my emergency election broadcast is now available - watch it before it's too late. Click here to watch it now. |
02/09/2024 3:31 PM | Campbell David Alan (Filed by) Janux Therapeutics (Subject)
| Form SC 13G/A | |
01/03/2024 3:49 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:50 PM | Janux Therapeutics (Issuer) Meyer Andrew Hollman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:52 PM | Janux Therapeutics (Issuer) Reardon Tighe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:53 PM | Janux Therapeutics (Issuer) Robinson Byron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:54 PM | Janux Therapeutics (Issuer) Winter Charles M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:46 PM | Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:48 PM | Janux Therapeutics (Issuer) Reardon Tighe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 6:11 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |